Page last updated: 2024-08-22

trolamine salicylate and Glycogen Storage Disease Type V

trolamine salicylate has been researched along with Glycogen Storage Disease Type V in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erdoğan, B; Korkmaz, C; Üsküdar Cansu, D1

Reviews

1 review(s) available for trolamine salicylate and Glycogen Storage Disease Type V

ArticleYear
Can hyperuricemia predict glycogen storage disease (McArdle's disease) in rheumatology practice? (Myogenic hyperuricemia).
    Clinical rheumatology, 2019, Volume: 38, Issue:10

    Topics: Adult; Antirheumatic Agents; Arthritis; Arthritis, Gouty; Diagnosis, Differential; Diagnostic Errors; Female; Glycogen Storage Disease Type V; Humans; Hyperuricemia; Inflammation; Polymyositis; Uric Acid

2019